Interestingly, deficiencies in CD80 and CD86 molecules can prevent the progression of atherosclerosis in low-density lipoprotein receptor knockout (LDLR)−/− mice by suppressing proatherogenic type 1 T helper cell (Th1) immune responses [37]. Here, CD86 is linked to atherosclerosis.